|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US4873191A
(en)
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
US4870009A
(en)
|
1982-11-22 |
1989-09-26 |
The Salk Institute For Biological Studies |
Method of obtaining gene product through the generation of transgenic animals
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
IT1164225B
(it)
|
1983-05-13 |
1987-04-08 |
Anic Spa |
Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
|
|
US4736866A
(en)
|
1984-06-22 |
1988-04-12 |
President And Fellows Of Harvard College |
Transgenic non-human mammals
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
DE122007000007I1
(de)
|
1986-04-09 |
2007-05-16 |
Genzyme Corp |
Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
JP2972257B2
(ja)
|
1990-01-24 |
1999-11-08 |
株式会社日立製作所 |
パケット交換機
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US5080891A
(en)
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP1541682A3
(en)
|
1988-09-02 |
2005-07-06 |
Dyax Corp. |
Generation and selection of recombinant varied binding proteins
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
FR2646438B1
(fr)
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5459039A
(en)
|
1989-05-12 |
1995-10-17 |
Duke University |
Methods for mapping genetic mutations
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
EP0950707B1
(en)
|
1989-07-25 |
2009-02-18 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
AU635844B2
(en)
|
1989-11-06 |
1993-04-01 |
Cell Genesys, Inc. |
Production of proteins using homologous recombination
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5272071A
(en)
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
ES2087997T3
(es)
|
1990-01-12 |
1996-08-01 |
Cell Genesys Inc |
Generacion de anticuerpos xenogenicos.
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
IL98764A0
(en)
|
1990-07-10 |
1992-07-15 |
Smithkline Beecham Corp |
Oxamides
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
WO1992006180A1
(en)
|
1990-10-01 |
1992-04-16 |
University Of Connecticut |
Targeting viruses and cells for selective internalization by cells
|
|
WO1992009968A1
(en)
|
1990-11-27 |
1992-06-11 |
Cray Research, Inc. |
VECTOR WORD SHIFT BY Vo SHIFT COUNT IN VECTOR SUPERCOMPUTER PROCESSOR
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
CA2103064A1
(en)
|
1991-05-14 |
1992-11-15 |
George Y. Wu |
Targeted delivery of genes encoding immunogenic proteins
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
WO1992022635A1
(en)
|
1991-06-05 |
1992-12-23 |
University Of Connecticut |
Targeted delivery of genes encoding secretory proteins
|
|
CA2110799A1
(en)
|
1991-06-14 |
1992-12-23 |
Arnold H. Horwitz |
Microbially-produced antibody fragments and their conjugates
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
WO1993014188A1
(en)
|
1992-01-17 |
1993-07-22 |
The Regents Of The University Of Michigan |
Targeted virus
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
WO1993020221A1
(en)
|
1992-04-03 |
1993-10-14 |
Young Alexander T |
Gene therapy using targeted viral vectors
|
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
|
ES2136664T3
(es)
|
1992-06-09 |
1999-12-01 |
Hoppe Ag |
Sistema de cierre y conjunto de cerradura.
|
|
FR2694851B1
(fr)
|
1992-08-12 |
1994-12-23 |
Sgs Thomson Microelectronics |
Circuit de tirage vers un état déterminé d'une entrée de circuit intégré.
|
|
WO1994004670A1
(en)
|
1992-08-26 |
1994-03-03 |
President And Fellows Of Harvard College |
Use of the cytokine ip-10 as an anti-tumor agent
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
WO1994008598A1
(en)
|
1992-10-09 |
1994-04-28 |
Advanced Tissue Sciences, Inc. |
Liver reserve cells
|
|
DE69333969T2
(de)
|
1992-10-30 |
2006-09-14 |
The General Hospital Corp., Boston |
Wechselwirkendes Fallensystem zur Isolierung von Proteinen
|
|
JPH08503855A
(ja)
|
1992-12-03 |
1996-04-30 |
ジェンザイム・コーポレイション |
嚢胞性線維症に対する遺伝子治療
|
|
US5547835A
(en)
|
1993-01-07 |
1996-08-20 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US5498531A
(en)
|
1993-09-10 |
1996-03-12 |
President And Fellows Of Harvard College |
Intron-mediated recombinant techniques and reagents
|
|
WO1995015982A2
(en)
|
1993-12-08 |
1995-06-15 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
DE69531148T2
(de)
|
1994-01-31 |
2004-04-29 |
Trustees Of Boston University, Boston |
Bibliotheken aus polyklonalen antikörpern
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
EP0822830B1
(en)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Human anti-IL-8 antibodies, derived from immunized xenomice
|
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
GB9517779D0
(en)
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
GB9517780D0
(en)
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP2305027B1
(en)
|
1996-12-03 |
2014-07-02 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
|
US6878687B1
(en)
|
1997-03-07 |
2005-04-12 |
Human Genome Sciences, Inc. |
Protein HMAAD57
|
|
US6420526B1
(en)
|
1997-03-07 |
2002-07-16 |
Human Genome Sciences, Inc. |
186 human secreted proteins
|
|
US20030049618A1
(en)
|
1997-03-07 |
2003-03-13 |
Ruben Steven M. |
186 human secreted proteins
|
|
WO1998039446A2
(en)
|
1997-03-07 |
1998-09-11 |
Human Genome Sciences, Inc. |
70 human secreted proteins
|
|
WO1998039448A2
(en)
|
1997-03-07 |
1998-09-11 |
Human Genome Sciences, Inc. |
186 human secreted proteins
|
|
US20030175858A1
(en)
|
1997-03-07 |
2003-09-18 |
Ruben Steven M. |
186 human secreted proteins
|
|
SI0970126T1
(en)
|
1997-04-14 |
2001-08-31 |
Micromet Ag |
Novel method for the production of antihuman antigen receptors and uses thereof
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
EP1022286A4
(en)
|
1997-10-07 |
2003-04-09 |
Ono Pharmaceutical Co |
POLYPEPTIDES, FOR ENDING CODNA AND THEIR USE
|
|
US6656906B1
(en)
|
1998-05-20 |
2003-12-02 |
Trimeris, Inc. |
Hybrid polypeptides with enhanced pharmacokinetic properties
|
|
EP1090118A2
(en)
|
1998-06-26 |
2001-04-11 |
Incyte Pharmaceuticals, Inc. |
Human signal peptide-containing proteins
|
|
US20030211510A1
(en)
|
1999-06-30 |
2003-11-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6504010B1
(en)
|
1999-06-30 |
2003-01-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US20020197669A1
(en)
|
2000-12-13 |
2002-12-26 |
Bangur Chaitanya S. |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6509448B2
(en)
|
1999-06-30 |
2003-01-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6858204B2
(en)
|
1999-06-30 |
2005-02-22 |
Corxia Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US20020172952A1
(en)
|
1999-06-30 |
2002-11-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US20030170255A1
(en)
|
1999-06-30 |
2003-09-11 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
WO2001053312A1
(en)
|
1999-12-23 |
2001-07-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
ES2270893T3
(es)
|
1999-12-24 |
2007-04-16 |
Genentech, Inc. |
Procedimiento y composiciones para prolongar la vida media de compuestos bioactivos.
|
|
JP2003533187A
(ja)
|
2000-05-03 |
2003-11-11 |
アムジエン・インコーポレーテツド |
治療薬としてのＦｃドメインを含む修飾ペプチド
|
|
WO2001090304A2
(en)
|
2000-05-19 |
2001-11-29 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
CN1454214A
(zh)
|
2000-08-02 |
2003-11-05 |
赛莱技术公司 |
具有增高功效的修饰生物肽
|
|
US20030134283A1
(en)
|
2000-10-03 |
2003-07-17 |
Peterson David P. |
Genes regulated in dendritic cell differentiation
|
|
EP1351702B1
(en)
*
|
2000-12-08 |
2015-03-04 |
Bioprovar Corporation |
Trem-1 splice variant for use in modifying immune responses
|
|
CA2342376C
(en)
*
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US20040259780A1
(en)
|
2001-07-30 |
2004-12-23 |
Glasebrook Andrew Lawrence |
Method for treating diabetes and obesity
|
|
WO2003025138A2
(en)
|
2001-09-17 |
2003-03-27 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
|
|
JP4381140B2
(ja)
|
2001-10-12 |
2009-12-09 |
シェーリング コーポレイション |
免疫応答を調節するための二重特異性抗体の使用
|
|
US20030211078A1
(en)
|
2001-12-07 |
2003-11-13 |
Heavner George A. |
Pseudo-antibody constructs
|
|
ES2425738T3
(es)
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
|
EP1329227A1
(en)
|
2002-01-22 |
2003-07-23 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Diagnostic conjugate useful for intercellular imaging and for differentiating between tumor- and non-tumor cells
|
|
US20060263770A1
(en)
|
2002-03-22 |
2006-11-23 |
Marco Colonna |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US20030191056A1
(en)
|
2002-04-04 |
2003-10-09 |
Kenneth Walker |
Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
|
|
WO2004020591A2
(en)
|
2002-08-29 |
2004-03-11 |
Five Prime Therapeutics, Inc. |
Methods of use for novel human polypeptides encoded by polynucleotides
|
|
EP1543030A2
(en)
|
2002-09-25 |
2005-06-22 |
Theratechnologies Inc. |
Modified glp-1 peptides with increased biological potency
|
|
GB0305478D0
(en)
*
|
2003-03-10 |
2003-04-16 |
Bioxell Spa |
Diagnostic and prognostic compounds and method
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
DE10316701A1
(de)
|
2003-04-09 |
2004-11-04 |
Hinzmann, Bernd, Dr. |
Humane Nukleinsäuresequenzen aus Bronchialkarzinomen
|
|
US20070083333A1
(en)
|
2003-11-17 |
2007-04-12 |
Vitiello Maria A |
Modeling of systemic inflammatory response to infection
|
|
GB0401730D0
(en)
|
2004-01-27 |
2004-03-03 |
Bioxell Spa |
Diagnosis method
|
|
JP2007531715A
(ja)
|
2004-03-17 |
2007-11-08 |
イーライ リリー アンド カンパニー |
グリコール結合ｆｇｆ−２１化合物
|
|
DK1751184T3
(da)
|
2004-05-13 |
2009-11-23 |
Lilly Co Eli |
FGF-21 fusionsproteiner
|
|
MX2007002616A
(es)
|
2004-09-02 |
2007-05-16 |
Lilly Co Eli |
Muteinas de factor de crecimiento de fibroblasto 21.
|
|
WO2006028714A1
(en)
|
2004-09-02 |
2006-03-16 |
Eli Lilly And Company |
Muteins of fibroblast growth factor 21
|
|
GB0426146D0
(en)
*
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
NZ543660A
(en)
|
2004-11-29 |
2008-01-31 |
Bioxell Spa |
Therapeutic peptides and method
|
|
US7655627B2
(en)
|
2004-12-14 |
2010-02-02 |
Eli Lilly And Company |
Muteins of fibroblast growth factor 21
|
|
US20080261875A1
(en)
|
2005-01-21 |
2008-10-23 |
Eli Lilly And Company |
Method For Treating Cardiovascular Disease
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
US20070099209A1
(en)
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
EP2418223A3
(en)
|
2006-06-12 |
2013-01-16 |
Emergent Product Development Seattle, LLC |
Single-chain multivalent binding proteins with effector function
|
|
MX2009007368A
(es)
|
2007-01-16 |
2009-07-16 |
Wyeth Corp |
Deteccion, tratamiento y monitoreo de la inflamacion, por medio del receptor de disparo expresado en la celula 1 mieloide (trem-1).
|
|
PL2068909T3
(pl)
|
2007-03-30 |
2012-09-28 |
Ambrx Inc |
Modyfikowane polipeptydy fgf-21 i ich zastosowanie
|
|
WO2009018386A1
(en)
|
2007-07-31 |
2009-02-05 |
Medimmune, Llc |
Multispecific epitope binding proteins and uses thereof
|
|
JP2010535781A
(ja)
|
2007-08-03 |
2010-11-25 |
イーライ リリー アンド カンパニー |
肥満に対する処置
|
|
US20100261637A1
(en)
|
2007-09-05 |
2010-10-14 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
US7914734B2
(en)
|
2007-12-19 |
2011-03-29 |
Singulex, Inc. |
Scanning analyzer for single molecule detection and methods of use
|
|
WO2009126380A2
(en)
|
2008-03-05 |
2009-10-15 |
Singulex, Inc. |
Methods and compositions for highly sensitive detection of molecules
|
|
EP2300829B1
(en)
|
2008-05-23 |
2014-07-23 |
Pronota NV |
New biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
|
|
BRPI0915448A2
(pt)
|
2008-07-08 |
2015-11-10 |
Abbott Lab |
imunoglobulinas de domínio variável duplo para prostaglandina e2 e usos das mesmas
|
|
NZ590988A
(en)
|
2008-08-25 |
2012-08-31 |
Janssen Biotech Inc |
Biomarkers for anti-tnf treatment in ulcerative colitis and related disorders
|
|
EP2358749B1
(en)
|
2008-10-10 |
2018-07-18 |
Amgen, Inc |
Fgf21 mutants and uses thereof
|
|
WO2010065439A1
(en)
|
2008-12-05 |
2010-06-10 |
Eli Lilly And Company |
Variants of fibroblast growth factor 21
|
|
ES2692495T3
(es)
|
2009-01-23 |
2018-12-03 |
Novo Nordisk A/S |
Derivados del FGF21 con aglutinante de albúmina A-B-C-D-E- y sus usos
|
|
WO2010132370A2
(en)
|
2009-05-11 |
2010-11-18 |
Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Soluble tlt-1 for the treatment and diagnosis of sepsis
|
|
US20120172298A1
(en)
|
2009-06-11 |
2012-07-05 |
Novo Nordisk A/S |
Glp-1 and fgf21 combinations for treatment of diabetes type 2
|
|
WO2011005481A1
(en)
|
2009-06-22 |
2011-01-13 |
Medimmune, Llc |
ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
US8513185B2
(en)
|
2009-10-13 |
2013-08-20 |
Alexander B. Sigalov |
Inhibition of TREM receptor signaling with peptide variants
|
|
MX2012006406A
(es)
|
2009-12-04 |
2012-07-25 |
Genentech Inc |
Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos.
|
|
US8362210B2
(en)
|
2010-01-19 |
2013-01-29 |
Xencor, Inc. |
Antibody variants with enhanced complement activity
|
|
EP2563812A4
(en)
|
2010-04-30 |
2016-01-13 |
Alexion Pharma Inc |
ANTIBODIES WITH REDUCED IMMUNOGENITY IN HUMANS
|
|
WO2012064733A2
(en)
|
2010-11-09 |
2012-05-18 |
Medimmune, Llc |
Antibody scaffold for homogenous conjugation
|
|
US20120195900A1
(en)
|
2010-12-22 |
2012-08-02 |
Abbott Laboratories |
Tri-variable domain binding proteins and uses thereof
|
|
UY33827A
(es)
|
2010-12-22 |
2012-07-31 |
Abbott Lab |
Proteínas de unión a media-inmunoglobulina y sus usos
|
|
US20120213781A1
(en)
|
2011-02-11 |
2012-08-23 |
Zyngenia, Inc. |
Monovalent and Multivalent Multispecific Complexes and Uses Thereof
|